Renaissance Technologies (RenTech)'s RVMD Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 6,200 shares of Revolution Medicines, Inc. (RVMD) worth $602,950, representing 0.00% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in RVMD, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 142,804 shares. Largest reduction occurred in Q4 2025, reducing 253,104 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Revolution Medicines (RVMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Revolution Medicines (RVMD) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +6,200 | New Buy | 6,200 | $97.25 |
| Q4 2025 | -253,104 | Sold Out | 0 | $0.00 |
| Q3 2025 | +9,600 | Add 3.94% | 253,104 | $46.70 |
| Q2 2025 | +100,700 | Add 70.52% | 243,504 | $36.79 |
| Q1 2025 | +142,804 | New Buy | 142,804 | $35.36 |
| Q2 2023 | -43,300 | Sold Out | 0 | $0.00 |
| Q1 2023 | +43,300 | New Buy | 43,300 | $0.02 |
| Q4 2022 | -68,900 | Sold Out | 0 | $0.00 |
| Q3 2022 | +68,900 | New Buy | 68,900 | $19.72 |
| Q1 2022 | -55,100 | Sold Out | 0 | $0.00 |
| Q4 2021 | +55,100 | New Buy | 55,100 | $25.17 |
| Q3 2021 | -22,900 | Sold Out | 0 | $0.00 |
| Q2 2021 | +13,300 | Add 138.54% | 22,900 | $31.75 |
| Q1 2021 | +9,600 | New Buy | 9,600 | $45.83 |
Renaissance Technologies (RenTech)'s Revolution Medicines Investment FAQs
Renaissance Technologies (RenTech) first purchased Revolution Medicines, Inc. (RVMD) in Q1 2021, acquiring 9,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Revolution Medicines, Inc. (RVMD) for 14 quarters since Q1 2021.
Renaissance Technologies (RenTech)'s largest addition to Revolution Medicines, Inc. (RVMD) was in Q1 2025, adding 142,804 shares worth $5.05 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 6,200 shares of Revolution Medicines, Inc. (RVMD), valued at approximately $602,950.
As of the Q1 2026 filing, Revolution Medicines, Inc. (RVMD) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Revolution Medicines, Inc. (RVMD) was 253,104 shares, as reported at the end of Q3 2025.